Add to ORKGWithin the past few years, increasing concerns have arisen about the ways in which corporate sponsorship of clinical trials and continuing medical education activities may bias the information that is published and disseminated about the benefits and risks of medications. Questions have also been raised about the extent of industry influence on the American Psychiatric Association’s diagnostic and treatment guidelines—namely, its DSM and Clinical Practice Guidelines
A thirty-five year escalation of emphasis on biological causation has rendered, for many, medication...
Although the educational flagships of many medical specialties proudly fly the colours of their drug...
As the efficacy and science of psychopharmaceuticals has become increasingly uncertain, marketing of...
Within the past few years, increasing concerns have arisen about the ways in which corporate sponsor...
The profession of medicine is predicated upon an ethical mandate: first do no harm. However, critics...
The revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM), scheduled for publi...
A recent letter to the American Psychiatric Association (APA) from Sen Chuck Grassley about the APA’...
All medical subspecialties have been subject to increased scrutiny about the ways by which their fin...
Clinicians practicing today need to be aware of the ways in which the current industry-dominated cli...
Undue industry influence may be compromising the very guidelines that doctors rely on for diagnosing...
Concerns about the pharmaceutical industry’s influence in academic medical centers and on medical ed...
In response to increasing public distrust and congressional concerns regarding pharmaceutical compan...
In June 2010, the Association of American Medical Colleges issued the third and final portion of its...
The purpose of this essay is to explore how the pharmaceutical industry’s influence impacts the drug...
The proliferating connections bet-ween physicians and the pharmaceutical industry have brought the c...
A thirty-five year escalation of emphasis on biological causation has rendered, for many, medication...
Although the educational flagships of many medical specialties proudly fly the colours of their drug...
As the efficacy and science of psychopharmaceuticals has become increasingly uncertain, marketing of...
Within the past few years, increasing concerns have arisen about the ways in which corporate sponsor...
The profession of medicine is predicated upon an ethical mandate: first do no harm. However, critics...
The revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM), scheduled for publi...
A recent letter to the American Psychiatric Association (APA) from Sen Chuck Grassley about the APA’...
All medical subspecialties have been subject to increased scrutiny about the ways by which their fin...
Clinicians practicing today need to be aware of the ways in which the current industry-dominated cli...
Undue industry influence may be compromising the very guidelines that doctors rely on for diagnosing...
Concerns about the pharmaceutical industry’s influence in academic medical centers and on medical ed...
In response to increasing public distrust and congressional concerns regarding pharmaceutical compan...
In June 2010, the Association of American Medical Colleges issued the third and final portion of its...
The purpose of this essay is to explore how the pharmaceutical industry’s influence impacts the drug...
The proliferating connections bet-ween physicians and the pharmaceutical industry have brought the c...
A thirty-five year escalation of emphasis on biological causation has rendered, for many, medication...
Although the educational flagships of many medical specialties proudly fly the colours of their drug...
As the efficacy and science of psychopharmaceuticals has become increasingly uncertain, marketing of...